← European Medicine Shortage Tracker · all medicines
Almotriptan idrogenomalato currently has availability issues reported in 1 European register: Italy.
Shortage ATC — · also listed as: ALMOTRIPTAN IDROGENOMALATO · data refreshed 7 August 2026
As of 7 August 2026, 1 of the 10 tracked registers list current availability issues for Almotriptan idrogenomalato, covering 3 affected product presentations. The longest-running open report was filed in Italy on 2025-06-16 and has now been open for about 14 months. Where agencies state a cause, manufacturing problems lead with 3 of the 3 stated-cause reports. Momentum is current, not historical: 2 of the open reports were filed within the last 90 days. Registers in Italy indicate that alternatives or equivalents are available — a pharmacist or doctor can advise on switching.
| Where | Status & products | Since | Expected end | Reason / alternatives | Source |
|---|---|---|---|---|---|
| 🇮🇹 Italy | Shortage ALMOTRIPTAN AUROBINDO + 2 more productsALMOTRIPTAN MYLAN ALMOTRIPTAN ZENTIVA | 2025-06-16 | — | Problemi produttivi Alternatives: AIFA: equivalents with the same active substance are available. | register ↗ |
Every individual register entry for Almotriptan idrogenomalato in the tracked sources, newest first — including resolved and discontinued reports.
| Reg. | Product | Status | Reported | Expected end | Stated reason |
|---|---|---|---|---|---|
| 🇮🇹 IT | ALMOTRIPTAN MYLAN | Shortage | 2026-09-01 | — | Problemi produttivi |
| 🇮🇹 IT | ALMOTRIPTAN AUROBINDO | Shortage | 2026-08-10 | — | Problemi produttivi |
| 🇮🇹 IT | ALMOTRIPTAN ZENTIVA | Shortage | 2025-06-16 | — | Problemi produttivi |
Yes. As of 7 August 2026, availability issues are reported in: Italy. Availability is national — a shortage in one country does not mean it is short everywhere.
3 of the active register entries indicate alternatives or equivalents (same active substance or an alternative treatment). Do not switch on your own — a pharmacist or prescriber can confirm the right substitute in your country.
Directly from the official medicines-agency register that lists Almotriptan idrogenomalato: AIFA (Italy). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.
Pharmacies, patient sites and newsrooms are welcome to embed the live status of Almotriptan idrogenomalato — free, with attribution. Copy this snippet:
<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/almotriptan-idrogenomalato/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Almotriptan idrogenomalato availability in Europe"></iframe> <p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/almotriptan-idrogenomalato/">Almotriptan idrogenomalato shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>